A. Vogel AG

ACTIVE

Switzerlandwww.avogel-company.chPrivateEstablished: 1963-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1963

Overview

Trial Phase Distribution

Phase

Trials

Phase 4

46.7%

Phase 3

26.7%

Not Applicable

13.3%

Phase 2

6.7%

Trial Status Distribution

Completed

73.3%

Terminated

13.3%

Unknown

6.7%

Withdrawn

6.7%

Clinical Trials

Trials sponsored by this organization (15)

Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections

Phase 4

Completed

interventional

Nov 2020122 participants

Safety and Efficacy of the Sore Throat Lozenges to Treat Acute Sore Throats

Phase 4

Completed

interventional

Mar 201974 participants

Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections

Phase 2

Completed

interventional

Nov 2018246 participants

Study to Assess Safety and Efficacy of Nephrosolid Tbs to Stimulate Urinary Output in Non-patient Volunteers

Phase 3

Completed

interventional

Feb 201866 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations

A. Vogel AG

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (15)

Eschscholzia Study

Sleep Well Observation Study

Mental Balance Study

Echinaforce COVID-19 Shedding Study

Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections

Safety and Efficacy of the Sore Throat Lozenges to Treat Acute Sore Throats

Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections

Study to Assess Safety and Efficacy of Nephrosolid Tbs to Stimulate Urinary Output in Non-patient Volunteers

Approvals

News